These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26751207)

  • 1. Simplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide Ligation.
    Panpradist N; Beck IA; Chung MH; Kiarie JN; Frenkel LM; Lutz BR
    PLoS One; 2016; 11(1):e0145962. PubMed ID: 26751207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C.
    Mutsvangwa J; Beck IA; Gwanzura L; Manhanzva MT; Stranix-Chibanda L; Chipato T; Frenkel LM
    J Virol Methods; 2014 Dec; 210():36-9. PubMed ID: 25239368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya.
    Chung MH; Beck IA; Dross S; Tapia K; Kiarie JN; Richardson BA; Overbaugh J; Sakr SR; John-Stewart GC; Frenkel LM
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):246-53. PubMed ID: 25140907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies.
    Lalonde MS; Troyer RM; Syed AR; Bulime S; Demers K; Bajunirwe F; Arts EJ
    J Clin Microbiol; 2007 Aug; 45(8):2604-15. PubMed ID: 17567789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort.
    Panpradist N; Beck IA; Ruth PS; Ávila-Ríos S; García-Morales C; Soto-Nava M; Tapia-Trejo D; Matías-Florentino M; Paz-Juarez HE; Del Arenal-Sanchez S; Reyes-Terán G; Lutz BR; Frenkel LM
    AIDS; 2020 Jul; 34(9):1331-1338. PubMed ID: 32205723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous and sensitive detection of human immunodeficiency virus type 1 (HIV) drug resistant genotypes by multiplex oligonucleotide ligation assay.
    Ellis GM; Vlaskin TA; Koth A; Vaz LE; Dross SE; Beck IA; Frenkel LM
    J Virol Methods; 2013 Sep; 192(1-2):39-43. PubMed ID: 23660583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay.
    Wagner TA; Kress CM; Beck I; Techapornroong M; Wittayapraparat P; Tansuphasawasdikul S; Jourdain G; Ngo-Giang-Huong N; Lallemant M; Frenkel LM
    J Clin Microbiol; 2010 May; 48(5):1555-61. PubMed ID: 20181911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE.
    Dokuta S; Utaipat U; Praparattanapan J; Keitkarn J; Maneekarn N; Sirisanthana T; Supparatpinyo K
    J Virol Methods; 2013 Jun; 190(1-2):20-8. PubMed ID: 23562659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants.
    Beck IA; Crowell C; Kittoe R; Bredell H; Machaba M; Willamson C; Janssens W; Jallow S; van der Groen G; Shao Y; Jacob M; Samuel NM; de Rivera IL; Ngo-Giang-Huong N; Cassol S; Alemnji G; Frenkel LM
    J Acquir Immune Defic Syndr; 2008 Aug; 48(4):418-27. PubMed ID: 18614915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure.
    Jourdain G; Wagner TA; Ngo-Giang-Huong N; Sirirungsi W; Klinbuayaem V; Fregonese F; Nantasen I; Techapornroong M; Halue G; Nilmanat A; Wittayapraparat P; Chalermpolprapa V; Pathipvanich P; Yuthavisuthi P; Frenkel LM; Lallemant M;
    Clin Infect Dis; 2010 May; 50(10):1397-404. PubMed ID: 20377404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencing.
    Beck IA; Deng W; Payant R; Hall R; Bumgarner RE; Mullins JI; Frenkel LM
    J Clin Microbiol; 2014 Jul; 52(7):2320-7. PubMed ID: 24740080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Diversity and Drug Resistance Among Antiretroviral Treatment-Failed Individuals from 2010 to 2012 in Honghe, China.
    Yang C; Yang S; Li J; Yang B; Liu J; Li H; Bian Z
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):822-9. PubMed ID: 25919896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OLA-Simple: A software-guided HIV-1 drug resistance test for low-resource laboratories.
    Panpradist N; Beck IA; Vrana J; Higa N; McIntyre D; Ruth PS; So I; Kline EC; Kanthula R; Wong-On-Wing A; Lim J; Ko D; Milne R; Rossouw T; Feucht UD; Chung M; Jourdain G; Ngo-Giang-Huong N; Laomanit L; Soria J; Lai J; Klavins ED; Frenkel LM; Lutz BR
    EBioMedicine; 2019 Dec; 50():34-44. PubMed ID: 31767540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors.
    Beck IA; Mahalanabis M; Pepper G; Wright A; Hamilton S; Langston E; Frenkel LM
    J Clin Microbiol; 2002 Apr; 40(4):1413-9. PubMed ID: 11923366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014.
    Silverman RA; Beck IA; Kiptinness C; Levine M; Milne R; McGrath CJ; Bii S; Richardson BA; John-Stewart G; Chohan B; Sakr SR; Kiarie JN; Frenkel LM; Chung MH
    J Infect Dis; 2017 Dec; 216(12):1569-1578. PubMed ID: 29040633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
    Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
    PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing HIV-1 pretreatment drug resistance among antiretroviral-naïve adults initiating treatment between 2006 and 2014 in Nairobi, Kenya.
    Chung MH; Silverman R; Beck IA; Yatich N; Dross S; McKernan-Mullin J; Bii S; Tapia K; Stern J; Chohan B; Sakr SR; Kiarie JN; Frenkel LM
    AIDS; 2016 Jun; 30(10):1680-2. PubMed ID: 27058353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a point mutation assay for HIV drug resistance testing in Kenya.
    Duarte HA; Beck IA; Levine M; Kiptinness C; Kingoo JM; Chohan B; Sakr SR; Chung MH; Frenkel LM
    AIDS; 2018 Oct; 32(16):2301-2308. PubMed ID: 30005020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants.
    Church JD; Towler WI; Hoover DR; Hudelson SE; Kumwenda N; Taha TE; Eshleman JR; Eshleman SH
    AIDS Res Hum Retroviruses; 2008 Apr; 24(4):595-605. PubMed ID: 18370589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.